Fidia Farmaceutici buys controlling stake in Meditrina Pharmaceuticals

Business Forum
Italian pharmaceutical company Fidia Farmaceutici, specializing in regenerative medicine and the use of hyaluronic acid in advanced therapeutic applications, has purchased a majority stake in Meditrina Pharmaceuticals.

Meditrina Pharmaceuticals is a Romanian pharmaceutical distributor active in therapeutic areas such as dermatology, gynecology, urology, and nephrology. 

“This is a strategic transaction and reflects investors' confidence in the potential of the local pharmaceutical sector,” says Liliana Busoiu, Partner at EY Parthenon Financial Diligence Leader, Romania.

EY Romania has provided financial and tax advisory services to Fidia Farmaceutici.

RECOMMENDED
Romania sees more M&A deals on nine months
Industry

Romania sees more M&A deals on nine months

The Romanian mergers and acquisitions (M&A) market recorded 216 transactions in the first nine months (9M) of 2025, an 8.5% increase compared to the same period in 2024.

RECOMMENDED FROM THE HOME PAGE
Electrica secures grid permits for 700 MWh of storage
Energy

Electrica secures grid permits for 700 MWh of storage

Energy company Electrica informs investors and the capital market that it has obtained the technical grid connection permits (ATR) for 17 new battery energy storage projects (BESS), with a total capacity of approximately 700 MWh.

Energy

Romanian grid operator to support peak power consumption during heatwave

Romania's national electricity transmission network operator, Transelectrica, has halted scheduled maintenance shutdowns to ensure the grid operates at maximum capacity during an ongoing extreme heatwave. The preventive measures aim to mitigate operational risks associated with severe weather conditions.